Chikungunya Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Chikungunya symptoms include debilitating arthralgia (joint pain), swelling of joints, stiffness of joints, myalgia (muscular pain), headache, fatigue (weakness), nausea, vomiting and rash and fever. Treatment includes use of NSAIDs.
The Chikungunya Fever pipeline drugs market research report provides an analysis of the Chikungunya Fever drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chikungunya Fever and features dormant and discontinued projects.
Chikungunya Fever Pipeline Drugs Market Segmentation by Targets
The targets of the Chikungunya Fever pipeline drugs market are Chikungunya Virus E2 Protein, Chikungunya Virus E1 Protein, Nonstructural Protein 4, Collagenase 3, Glycoprotein, Nonstructural Protein 1, and Nonstructural Protein 3 among others.
Chikungunya Fever Pipeline Drugs Market Analysis, by Targets
To know more about the MoA in the Chikungunya Fever pipeline drugs market, download a free report sample
Chikungunya Fever Pipeline Drugs Market Segmentation by Mechanisms of Action
The mechanisms of action of Chikungunya Fever pipeline drugs market are Chikungunya Virus E2 Protein Inhibitor, Nonstructural Protein 4 Inhibitor, Chikungunya Virus E1 Protein Inhibitor, Collagenase 3 Inhibitor, Nonstructural Protein 1 Inhibitor, and Nonstructural Protein 3 Inhibitor among others.
Chikungunya Fever Pipeline Drugs Market Analysis, by Mechanisms of Action
To know more about the MoA in the Chikungunya Fever pipeline drugs market, download a free report sample
Chikungunya Fever Pipeline Drugs Market Segmentation by Routes of Administration
The routes of administration in the Chikungunya Fever pipeline drugs market are intramuscular, oral, subcutaneous, intravenous, nasal, parenteral, and transdermal.
Chikungunya Fever Pipeline Drugs Market Analysis, by Routes of Administration
To know more about the RoA in the Chikungunya Fever pipeline drugs market, download a free report sample
Chikungunya Fever Pipeline Drugs Market Segmentation by Molecule Types
The molecule types in the Chikungunya Fever pipeline drugs market are Recombinant Vector Vaccine, Monoclonal Antibody, Small Molecule, Subunit Vaccine, Inactivated Vaccine, DNA Vaccine, Live Attenuated Vaccine, and Vaccine among others.
Chikungunya Fever Pipeline Drugs Market Analysis, by Molecule Types
To know more about the molecule types in the Chikungunya Fever pipeline drugs market, download a free report sample
Competitive Landscape
Some of the leading companies in the Chikungunya Fever pipeline drugs market are Bharat Biotech Ltd, Emergent BioSolutions Inc, Inovio Pharmaceuticals Inc, Sementis Ltd, Activirosomes Ltd, Auro Vaccines LLC, BioNet-Asia Co Ltd, Bow Therapeutics, and Ciloa among others.
Chikungunya Fever Pipeline Drugs Market Analysis, by Leading Companies
To know more about the leading companies in the Chikungunya Fever pipeline drugs market , download a free report sample
Chikungunya Fever Pipeline Drugs Market Report Overview
Key Targets | Chikungunya Virus E2 Protein, Chikungunya Virus E1 Protein, Nonstructural Protein 4, Collagenase 3, Glycoprotein, Nonstructural Protein 1, and Nonstructural Protein 3 |
Key Mechanisms of Action | Chikungunya Virus E2 Protein Inhibitor, Nonstructural Protein 4 Inhibitor, Chikungunya Virus E1 Protein Inhibitor, Collagenase 3 Inhibitor, Nonstructural Protein 1 Inhibitor, and Nonstructural Protein 3 Inhibitor |
Key Routes of Administration | Intramuscular, Oral, Subcutaneous, Intravenous, Nasal, Parenteral, and Transdermal |
Key Molecule Types | Recombinant Vector Vaccine, Monoclonal Antibody, Small Molecule, Subunit Vaccine, Inactivated Vaccine, DNA Vaccine, Live Attenuated Vaccine, and Vaccine |
Key Companies | Bharat Biotech Ltd, Emergent BioSolutions Inc, Inovio Pharmaceuticals Inc, Sementis Ltd, Activirosomes Ltd, Auro Vaccines LLC, BioNet-Asia Co Ltd, Bow Therapeutics, and Ciloa |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Chikungunya Fever (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Chikungunya Fever (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Chikungunya Fever (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Chikungunya Fever (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Chikungunya Fever (Infectious Disease)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Chikungunya Fever (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Chikungunya Fever (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Auro Vaccines LLC
Bharat Biotech Ltd
BioNet-Asia Co Ltd
Bow Therapeutics
Ciloa
Collaborations Pharmaceuticals Inc
Emergent BioSolutions Inc
Emergex Vaccines Holding Ltd
Ennaid Therapeutics LLC
Hawaii Biotech Inc
ImmunityBio Inc
Imophoron Ltd
Indian Immunologicals Ltd
Inovio Pharmaceuticals Inc
Integral Molecular Inc
Integrated BioTherapeutics Inc
Medigen Inc
Meletios Therapeutics SAS
Merck & Co Inc
Najit Technologies Inc
Pai Life Sciences Inc
Paradigm Biopharmaceuticals Ltd
Precision Virologics Inc
ProtInhi BV
Riboscience LLC
Sementis Ltd
Shionogi & Co Ltd
Takeda Pharmaceutical Co Ltd
Technovalia Pty Ltd
Valneva SE
Vaxart Inc
VenatoRx Pharmaceuticals Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the targets of the Chikungunya Fever pipeline drugs market?
The targets of the Chikungunya Fever pipeline drugs market are Chikungunya Virus E2 Protein, Chikungunya Virus E1 Protein, Nonstructural Protein 4, Collagenase 3, Glycoprotein, Nonstructural Protein 1, and Nonstructural Protein 3.
-
What are the mechanisms of action of the Chikungunya Fever pipeline drugs market?
The key mechanisms of action of the Chikungunya Fever pipeline drugs market are Chikungunya Virus E2 Protein Inhibitor, Nonstructural Protein 4 Inhibitor, Chikungunya Virus E1 Protein Inhibitor, Collagenase 3 Inhibitor, Nonstructural Protein 1 Inhibitor, and Nonstructural Protein 3 Inhibitor.
-
What are the top routes of administration in the Chikungunya Fever pipeline drugs market?
The routes of administration in the Chikungunya Fever pipeline drugs market are intramuscular, oral, subcutaneous, intravenous, nasal, parenteral, and transdermal.
-
What are the molecule types in the Chikungunya Fever pipeline drugs market?
The molecule types in the Chikungunya Fever pipeline drugs market are Recombinant Vector Vaccine, Monoclonal Antibody, Small Molecule, Subunit Vaccine, Inactivated Vaccine, DNA Vaccine, Live Attenuated Vaccine, and Vaccine among others.
-
Which are the leading companies in the Chikungunya Fever pipeline drugs market?
Some of the leading companies in the Chikungunya Fever pipeline drugs market are Bharat Biotech Ltd, Emergent BioSolutions Inc, Inovio Pharmaceuticals Inc, Sementis Ltd, Activirosomes Ltd, Auro Vaccines LLC, BioNet-Asia Co Ltd, Bow Therapeutics, and Ciloa among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.